The key regulatory checkpoint for DNA replication completion before mitosis is:
Before mitosis, cells must verify complete and accurate genome duplication to avoid mitotic breakage of under-replicated chromosomes. G2/M checkpoint operates as surveillance system mediated by ATR-Chk1 and ATM-Chk2 kinases activated by RPA-coated single-stranded DNA at stalled forks and double-strand breaks respectively. Chief effectors are Cdc25 phosphatase family isoforms B and C that normally remove inhibitory Thr14 and Tyr15 phosphorylations placed on CDK1 by Wee1 and Myt1 nuclear kinases, triggering abrupt CDK1 activation. Checkpoint kinases phosphorylate Cdc25B/C at Ser216 and Ser323 generating 14-3-3 protein docking sites, leading to cytoplasmic sequestration away from nuclear cyclin B-CDK1 pool, keeping CDK1 inhibited. p53 pathway adds parallel inhibition via p21 induction and Gadd45 binding to PCNA-CDK1 complex. When replication finishes and lesions repaired, phosphatases PP2A and PP1 reverse checkpoint phosphorylations, allowing nuclear import of Cdc25 and autocatalytic amplification loop that drives lamin phosphorylation, chromosome condensation, and centrosome separation. Surveillance prevents premature segregation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.
Ref: Lodish et al., Molecular Cell Biology, 9th ed., Chapter 20: G2/M Checkpoint and Replication Completion.